Search

Search Constraints

You searched for: Author/Creator Apperley, Jane F.

Search Results

11. Clinical proof of concept for a safe and effective NF‐κB‐targeting strategy in multiple myeloma. (26th September 2018)

12. Cognitive dysfunction after withdrawal of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia. Issue 11 (3rd September 2016)

13. C‐reactive protein prior to myeloablative allogeneic haematopoietic cell transplantation identifies patients at risk of early‐ and long‐term mortality. (29th November 2016)

14. Durable humoral responses after the second anti‐SARS‐CoV‐2 vaccine dose in chronic myeloid leukaemia patients on tyrosine kinase inhibitors. (19th December 2021)

15. Identification of genetic targets in acute myeloid leukaemia for designing targeted therapy. (6th October 2020)

16. Impact of route and adequacy of nutritional intake on outcomes of allogeneic haematopoietic cell transplantation for haematologic malignancies. Issue 2 (April 2019)

17. Long-term persistence of natural anti-SARS-CoV-2 antibodies and mild impact of SARS-CoV-2 infection in CML patients: results from a seroprevalence study. Issue 6 (12th May 2022)

19. Mesenchymal stromal cells for acute graft‐versus‐host disease: response at 1 week predicts probability of survival. (13th January 2019)

20. Overall survival with ponatinib versus allogeneic stem cell transplantation in Philadelphia chromosome‐positive leukemias with the T315I mutation. Issue 15 (7th April 2017)